Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Accounts Payables (2022 - 2023)

Historic Accounts Payables for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $2.7 million.

  • Lexeo Therapeutics' Accounts Payables changed N/A to $2.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2022, which is N/A changed from last year.
  • Per Lexeo Therapeutics' latest filing, its Accounts Payables stood at $2.7 million for Q3 2023.
  • Lexeo Therapeutics' 5-year Accounts Payables high stood at $2.7 million for Q4 2022, and its period low was $2.7 million during Q3 2023.